16
Views
4
CrossRef citations to date
0
Altmetric
CORRESPONDENCE

Practical limitations of prescribing olanzapine depot (Relprevv)

Page 269 | Published online: 20 May 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Thomas R. Einarson, Colin Vicente, Roman Zilbershtein, Charles Piwko, Christel N. Bø, Hanna Pudas, Rasmus Jensen & Michiel E.H. Hemels. (2014) Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden. Nordic Journal of Psychiatry 68:6, pages 416-427.
Read now
Thomas R. Einarson, Hanna Pudas, Roman Zilbershtein, Rasmus Jensen, Colin Vicente, Charles Piwko & Michiel E. H. Hemels. (2013) Cost-effectiveness analysis of atypical long-acting antipsychotics for treating chronic schizophrenia in Finland. Journal of Medical Economics 16:9, pages 1096-1105.
Read now
Pierre Chue & James Chue. (2012) A review of olanzapine pamoate . Expert Opinion on Pharmacotherapy 13:11, pages 1661-1670.
Read now
Dieter Naber. (2011) Olanzapine pamoate for the treatment of schizophrenia. Expert Opinion on Pharmacotherapy 12:4, pages 627-633.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.